IP Library Granted Patent US 7,439,265
Granted Patent B2
US 7,439,265 · App. 10/580,572 · Granted Oct 21, 2008

Irciniastatins a and b

Assignee: Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behalf of Arizona State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,439,265
App. No.
10/580,572
Granted
Oct 21, 2008
Kind
B2
Abstract

The Indo-Pacific marine sponge Ircinia ramosa has been found to contain two powerful (GI50 0.001 to <0.0001 μg/ml) murine and human cancer cell growth inhibitors, denominated herein as irciniastatin A and irciniastatin B. Both were isolated (10-3 to 10-4% yields) by cancer cell line bioassay-guided techniques and named irciniastatins A (1) and B (2). Structural elucidation by a combination of spectral analyses, primarily high resolution mass and 2D-NMR (principally APT, HMQC, HMBC and ROESY) revealed unusual structures 1 and 2.

Claims (10)

1. An essentially pure compound having a structure as follows:

wherein R═OH and R 1 ═H.

2. An essentially pure compound having a structure as follows:

wherein R═R 1 ═O.

3. A pharmaceutical composition comprising the compound of claim 1 .

4. A pharmaceutical composition comprising the compound of claim 2 .

5. A method for treating cells or tissue afflicted with neoplastic disease, comprising administering an effective amount of the composition of claim 3 .

6. A method for treating cells or tissue afflicted with neoplastic disease, comprising administering an effective amount of the composition of claim 4 .

7. A method for treating humans and animals having cancer, comprising administering a pharmaceutically effective amount of the composition of claim 3 .

8. A method for treating humans and animals having cancer, comprising administering a pharmaceutically effective amount of the composition of claim 4 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 21, 2011
From: ARIZONA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025672/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2008
From: PETTIT, GEORGE R.; XU, JUN-PING
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 021470/0459 →
Continuity (2)
Provisional Application 6052556500 · Nov 25, 2003
Related Publication 20070135516A1 · Jun 14, 2007